CION Ameerpet
"Mass" is a word that lands hard, and it means less than it sounds like. It describes something taking up space on a scan — nothing more. Fibroids are masses. Benign cysts are masses. So is a full bowel loop, occasionally.
Radiologists use mass to mean any structure occupying space that is not supposed to be there. It is deliberately neutral — a word chosen precisely because it does not commit to a diagnosis. A fibroid is a mass. A benign ovarian cyst is a mass. A fluid-filled fallopian tube is a mass. A kidney sitting low in the pelvis, present since birth and entirely harmless, is a mass.
The word lands very differently than it is meant, and there is no getting around that. But it is worth holding onto the distinction, because the emotional weight the word carries is doing none of the diagnostic work. The features described alongside it are: whether it is cystic or solid, its size, where it arises from, whether it has internal blood flow, and whether there is free fluid in the abdomen.
Being told you have a pelvic mass means you have entered an assessment pathway. That pathway is well established, it usually moves quickly, and it ends in a specific answer. This page describes its shape — which is most of what people actually want to know while they are waiting.
Radiologists use "mass" precisely because it commits to nothing. The descriptors around it carry all the information.
Cysts, fibroids, endometriomas and hydrosalpinges account for the large majority of pelvic masses in women of any age.
A defined sequence of tests that ends in a specific answer, usually within weeks rather than months.
A meaningful share of masses reported as adnexal — meaning in the region of the ovary and tube — turn out not to arise from the ovary at all. Pedunculated fibroids growing on a stalk from the uterus, hydrosalpinges (fluid-filled fallopian tubes), paraovarian cysts sitting beside rather than within the ovary, and even a pelvic kidney can all be reported this way on a first scan. Establishing that a mass is not ovarian in origin substantially changes how it is viewed — which is one reason a dedicated transvaginal scan is worth more than escalating straight to blood tests. Source: standard gynaecological imaging practice.
Most women complete this sequence within a few weeks, and most reach a benign answer. Knowing the order removes much of the uncertainty.
Where the mass was found on a CT done for another reason, on a transabdominal scan, or on examination, a proper transvaginal scan with colour Doppler is the highest-value next step. It establishes where the mass arises from, what it contains, and whether there is blood flow within it — and it frequently gives the diagnosis outright. See reading a scan report.
CA-125 where an epithelial ovarian process is being considered — interpreted alongside the imaging and your menopausal status, never alone. In women under 40, additional markers including AFP, beta-hCG and LDH are added, because germ cell tumours are the relevant consideration at that age and they produce different markers. A full blood count and basic biochemistry complete the picture.
The imaging features, the marker results and your menopausal status are combined into a risk assessment — commonly the Risk of Malignancy Index. A low score supports local management or observation; a raised score directs referral to a specialist gynaecologic-oncology service. It is a triage tool for getting you to the right team, not a diagnosis.
An MRI of the pelvis characterises fat, blood products and fibrous tissue far better than ultrasound, so it reliably identifies dermoids, endometriomas and fibroids. Its main value is converting an indeterminate mass into a confident benign diagnosis and avoiding an operation done purely to find out.
Where the assessment points towards malignancy, a CT of the chest, abdomen and pelvis establishes the extent of disease rather than the nature of the mass. This is a staging test, and it is done to plan treatment rather than to make the diagnosis.
Cases raising a question are discussed by a multidisciplinary group — medical oncology, imaging and pathology — before a plan is set, rather than being decided by one clinician. At CION, chemotherapy and maintenance treatment are delivered in-house across 35+ centres; surgery, including cystectomy and any debulking procedure, is coordinated with specialist gynaecologic-oncology partner centres and may be billed there.
Roughly in order of frequency. Your final report will almost certainly name one of these rather than leaving it as "mass".
The commonest single explanation. Functional cysts in women who are ovulating, haemorrhagic cysts, simple cysts at any age, dermoids and endometriomas all present as adnexal masses and all are benign. Many resolve on their own; the rest are characterised on ultrasound and managed accordingly.
A repeat scan after six to twelve weeks distinguishes the resolving types from the persistent ones, and that distinction alone answers a large share of cases. See ovarian cysts explained.
Extremely common benign muscular growths of the uterus. A fibroid on a stalk, growing outward from the uterine wall, can sit alongside the ovary and be reported as an adnexal mass on a first scan — a genuinely frequent source of confusion that a good transvaginal scan or an MRI resolves.
Fibroids cause pressure symptoms, heavy periods and sometimes urinary frequency, and they are managed on symptoms rather than on their presence. Establishing that a mass is a fibroid rather than an ovarian lesion changes the entire picture.
A hydrosalpinx is a fallopian tube blocked and distended with fluid, usually following previous pelvic infection, endometriosis or surgery. It has a characteristic tubular shape with incomplete septations, quite unlike an ovarian cyst once recognised.
It is benign. It matters mainly because it affects fertility and can cause pelvic pain, and because it is a common reason for a mass to be reported near the ovary when the ovary itself is entirely normal.
An endometrioma is a benign ovarian cyst filled with old altered blood, with a characteristic ground-glass appearance on ultrasound. Deep endometriosis elsewhere in the pelvis can also produce nodular masses that are visible on imaging, particularly on MRI.
Both are benign, and both usually come with a history of severe period pain, deep pain during sex and chronic pelvic pain. See endometrioma.
Not everything in the pelvis is gynaecological. A pelvic kidney — a kidney that developed low in the pelvis rather than in its usual position — is harmless and lifelong. Bowel-related masses, including diverticular disease and appendiceal collections, present in the pelvis. Peritoneal inclusion cysts follow previous surgery.
Abdominal tuberculosis deserves specific mention in this region, because it can produce pelvic masses, ascites and a raised CA-125 that together closely mimic ovarian malignancy — and it is entirely treatable. A good work-up considers it rather than assuming the worst diagnosis.
Borderline tumours have abnormal cells but do not invade surrounding tissue as a cancer does. They occur more often in younger women, are usually confined to the ovary when found, and have a substantially better outlook than ovarian cancer. Fertility-preserving surgery is often possible.
Ovarian malignancy is the least common answer on this list. The features pointing towards it are solid components, papillary projections, thick irregular septations, strong internal blood flow, ascites and bilateral disease, particularly after the menopause. Where these are present, referral into a specialist service is prompt and the pathway is well defined.
None of these means cancer. Each raises the urgency of characterisation and may prompt specialist referral sooner.
Solid tissue inside the mass that has its own blood supply is the single most important combination on any imaging report.
Free fluid in the abdomen alongside a pelvic mass changes the assessment materially and prompts prompt further imaging.
Bilateral adnexal masses are assessed more urgently than the same finding confined to one side.
More meaningful after the menopause, because the common benign causes of elevation are largely absent by then.
A mass that has clearly enlarged between scans is behaving differently from a stable one and warrants prompt reassessment.
Persistent bloating or unintended weight loss alongside a pelvic mass raises the priority of the work-up.
Being referred to a gynaecologic-oncology service is not a diagnosis. It is how the system makes sure indeterminate masses are assessed by the team best placed to characterise them.
Most of the distress in this situation comes from not knowing what happens next or how long it takes. Forty-five minutes usually replaces that with a clear sequence.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Trained at AIIMS, Tata Memorial and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them - together.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Bring the scan report and images — most masses have a benign explanation that can be named.
The hardest part of this situation is usually not the mass. It is the gap — between being told something was found and being told what it is. That gap is often filled with a phone call that offers no interpretation, an appointment date some weeks away, and a great deal of searching in between.
Your first consultation at CION is free and runs to about 45 minutes. Bring the scan report and, if you can, the images or the disc. In a large share of cases the useful outcome is straightforward: identifying what the mass most likely is, explaining what the next test is actually for, and being specific about the timeline. Where a better scan would answer more than another blood test, we will say so.
Where the assessment does point towards malignancy, CION delivers medical oncology in-house — chemotherapy and maintenance therapy across 35+ centres in Telangana and Andhra Pradesh — alongside genetic counselling where family history or the diagnosis warrants it. Surgery, including cystectomy and any debulking procedure, is coordinated with specialist gynaecologic-oncology partner centres and may be billed there. We state that upfront rather than leaving it to be discovered later.
Free and unhurried. Long enough to explain the pathway, the tests and the timeline rather than summarise them in a sentence.
A dedicated transvaginal scan with Doppler resolves many indeterminate masses into a confident benign diagnosis.
Cases raising a question are reviewed by a multidisciplinary group before a plan is set, rather than decided by one clinician.
Scans, follow-up and any subsequent care near where you live across Telangana and Andhra Pradesh.
A quick reference to what each step in the pathway is actually for. The recurring theme: no single result decides anything alone.
| Test | The question it answers | What it cannot do |
|---|---|---|
| Transvaginal ultrasound | Where does it arise from, what is inside it, is there blood flow? | Cannot give a tissue diagnosis; occasionally cannot characterise confidently. |
| Colour Doppler | Do any solid areas have a blood supply? | Flow alone neither confirms nor excludes malignancy. |
| CA-125 | Adds weight alongside imaging, especially after menopause. | Not a screening test. Raised by many benign conditions; normal in some early cancers. |
| AFP, beta-hCG, LDH | Are germ cell markers raised? Relevant under 40. | Not useful in older women, where epithelial tumours predominate. |
| MRI pelvis | Is this a dermoid, endometrioma or fibroid? Characterises tissue. | Not a staging test; does not assess the chest or upper abdomen. |
| CT chest/abdomen/pelvis | How far does disease extend? Used for staging. | Poor at characterising the nature of a small adnexal mass. |
| Histopathology | The definitive diagnosis. | Requires the mass to be removed or sampled. |
*In women under 40 the marker panel differs, because germ cell tumours rather than epithelial tumours are the relevant consideration at that age.
No. Mass is a deliberately neutral radiological term meaning a structure occupying space that should not be there, and it commits to no diagnosis at all. The great majority of pelvic masses in women are benign: ovarian cysts of all types, uterine fibroids, endometriomas, hydrosalpinges and paraovarian cysts between them account for most findings. Some masses reported as adnexal turn out not to arise from the ovary at all. The features described alongside the word — cystic or solid, size, origin, internal blood flow, and whether there is free fluid — carry all of the actual information.
Most women complete the assessment within a few weeks rather than months. A dedicated transvaginal ultrasound with Doppler is usually arranged quickly and frequently gives the diagnosis outright. Where blood tests are needed they return within days. Where an MRI is required to characterise an indeterminate mass, that adds a short wait. Where features are concerning, the pathway accelerates deliberately — referral to a specialist service happens promptly rather than in routine order. If you have been given a long wait and your report describes concerning features, it is reasonable to ask for that to be reviewed.
Because they answer different questions. Ultrasound is excellent at showing structure and blood flow and is the right first test, but a minority of masses remain indeterminate on it. MRI is substantially better at characterising specific tissue types — it can identify fat, blood products and fibrous tissue with confidence — so it reliably distinguishes dermoids, endometriomas and fibroids from anything of concern. Its main value is converting an indeterminate result into a definite benign diagnosis, which frequently avoids an operation that would otherwise have been done simply to find out.
No. Referral into a gynaecologic-oncology service is how the system makes sure that any mass which cannot be confidently characterised is assessed by the team with the most experience of characterising them. A substantial proportion of women referred this way turn out to have benign disease, and many need no surgery at all. The referral reflects the level of uncertainty in the imaging, not a conclusion about what the mass is. It is worth asking directly what the risk assessment showed and what specifically prompted the referral.
Because the relevant markers depend on your age. In women over about 40, epithelial ovarian tumours are the main consideration and CA-125 is the marker used, sometimes with HE4. In women under 40, germ cell tumours are relatively more common, and those produce different substances — so AFP, beta-hCG and LDH are added to the panel. Ordering the wrong markers for the age group is a genuine and avoidable gap. If you are under 40 and only a CA-125 was checked, it is reasonable to ask whether the germ cell markers should also be done.
Yes, and it is worth keeping in view. A pelvic kidney — a kidney that developed low in the pelvis instead of its usual position — is harmless and lifelong but can be reported as a pelvic mass. Bowel-related masses including diverticular disease present in the pelvis. Peritoneal inclusion cysts follow previous surgery. In this region abdominal tuberculosis deserves specific mention: it can produce pelvic masses, ascites and a raised CA-125 that together closely mimic ovarian malignancy, and it is entirely treatable. A thorough work-up considers these rather than assuming.
The first consultation is free and runs to about 45 minutes — bring the scan report and the images if you have them. CION delivers medical oncology in-house, covering chemotherapy and maintenance treatment across more than 35 centres in Telangana and Andhra Pradesh, alongside genetic counselling where family history or a diagnosis warrants it. Every case that raises a question is reviewed at a tumour board rather than decided by one doctor. Surgery, including cystectomy and debulking, is coordinated with specialist gynaecologic-oncology partner centres and may be billed there, and we state that upfront.